Sonedenoson

DB12443InvestigationalSmall molecule

Sonedenoson has been used in trials studying the treatment of Foot Ulcer, Diabetic and Diabetes Complications.

Mechanism: Pharmacologically active on Adenosine receptor A2a
Curator reviewed
Formula / weight: C₁₈H₂₀ClN₅O₅ · 421.84 g/mol (avg)
Code names: MRE0094

Resolves to

Compound

Structure

InChIKeyWUCQGGOGHZRELS-LSCFUAHRSA-NSMILESNC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC(OCCC2=CC=C(Cl)C=C2)=N1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Sonedenoson, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.